Posted by Michael Wonder on 24 Apr 2023
EMA publishes agenda for 24-26 April 2023 CHMP meeting
24 April 2023 - The EMA has published a draft agenda for this week's CHMP meeting.
The CHMP is due to issue opinions for the following technologies:
- Respiratory syncytial virus pre-fusion F protein, adjuvanted with AS01E (RSVPref3)
- Glofitamab
- Pirtubrutinib
- Futibatinib
- Miglustat
- Sugammadex sodium
